Pharmacology

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Intravenous conscious sedation (IVCS) aims for patient comfort without compromising vital functions.
• Deep sedation, characterized by loss of protective reflexes and unresponsiveness, is a complication to be avoided.

Purpose of the Study:

• To emphasize patient risk factors and drug considerations for safe IVCS.
• To guide clinicians in preventing deep sedation and its associated complications.

Main Methods:

• Review of drug metabolism, excretion, and potential interactions relevant to IVCS.
• Identification of patient populations at increased risk for adverse sedation effects.

Main Results:

• Elderly patients, those with COPD, low serum albumin, or poor cardiac function require dose adjustments.
• Drugs with active metabolites (e.g., diazepam, meperidine) or those with prolonged effects (e.g., fentanyl) necessitate careful titration.
• Drug interactions (e.g., cimetidine with diazepam) can prolong sedation.

Conclusions:

• Safe IVCS requires careful drug titration, awareness of patient-specific risk factors, and understanding of pharmacokinetic principles.
• Maintaining a patent airway and responsiveness is paramount, achievable with vigilant monitoring and appropriate drug management.